HappeningToo topic
Tirzepatide reports
Browse community reports connected to Tirzepatide. These reports can show that other people are describing similar experiences, but they do not prove that Tirzepatide caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
42 problems
Abdominal Discomfort while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and abdominal discomfort appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and abdominal distension appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and abdominal pain upper appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and abdominal pain appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and acid reflux appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and alopecia appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and anxiety appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and back pain appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and chills appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and constipation appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and cough appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and decreased appetite appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and dehydration appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and diarrhea appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and dizziness appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and dry mouth appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and dyspepsia appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and fatigue appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and feeling abnormal appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and flatulence appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and headache appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and heart rate increased appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and hives appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Increased Appetite while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and increased appetite appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and insomnia appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and itching appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and malaise appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and muscle spasms appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and myalgia appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and nausea appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and pain appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and palpitations appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and rash appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and shortness of breath appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and sleepiness appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and tingling or pins and needles appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and tremor appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and vision blurred appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and vomiting appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and weakness appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and weight decreased appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Tirzepatide
FDA FAERS contains adverse-event reports in which Tirzepatide and weight increased appear together. This does not establish that Tirzepatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →